Target intelligence / Profile preview

Novel transcript, antisense to RASAL1 (ENSG00000295497)

Target
ENSG00000295497
Molecular classification
Other, Natural antisense transcript, non-coding RNA
01

Overview

This entry refers to a natural antisense transcript (NAT) at the RASAL1 gene locus. NATs are a class of non-coding RNAs that are transcribed from the DNA strand opposite to a protein-coding "sense" gene, in this case RASAL1. Antisense transcripts can play regulatory roles by interacting with the corresponding sense mRNA, potentially influencing gene expression through mechanisms such as RNA masking, modulation of splicing, epigenetic regulation (such as DNA methylation), and post-transcriptional gene silencing. However, the specific function, expression pattern, and biological significance of this particular antisense transcript (ENSG00000295497) are uncharacterized. It is not considered a therapeutic target, does not encode a protein, and is not associated with any drugs or biomarker roles. Most antisense transcripts are only annotated by sequencing and lack experimental validation or disease association.

Other names
novel transcript, antisense to RASAL1ENSG00000295497
02

Mechanism of action

Not established. Antisense transcripts can generally regulate sense gene expression at the transcriptional, post-transcriptional, and epigenetic levels, including RNA masking, modulation of splicing, and initiation of RNA interference, based on broader NAT biology.

03

Biological functions

Regulation of gene expressionpotential epigenetic modulationtranscriptional interferenceRNA maskingpossible involvement in RNA interference
04

Disease associations

No direct evidence for disease involvement specific to this transcriptAntisense transcripts near tumor suppressor genes may be involved in silencing or regulation in cancer (indirect and hypothetical)

Beyond the preview

Go deeper on Novel transcript, antisense to RASAL1 (ENSG00000295497).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to RASAL1 (ENSG00000295497).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call